WBR0896: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |QuestionAuthor={{AO}} |ExamType=USMLE Step 3 |MainCategory=Emergency Room |SubCategory=Neurology |MainCategory=Emergency Room |SubCategory=Neurology |MainCatego...")
 
m (refreshing WBR questions)
 
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{AO}}
|QuestionAuthor= {{AO}}
|ExamType=USMLE Step 3
|ExamType=USMLE Step 3
|MainCategory=Emergency Room
|MainCategory=Emergency Room

Latest revision as of 02:01, 28 October 2020

 
Author [[PageAuthor::Ayokunle Olubaniyi, M.B,B.S [1]]]
Exam Type ExamType::USMLE Step 3
Main Category MainCategory::Emergency Room
Sub Category SubCategory::Neurology
Prompt [[Prompt::A 66-year-old woman with a past medical history of hypertension, osteoarthritis, and depression is brought to the ED with an acute onset of impaired speech, right-sided hemiplegia, and right-sided facial palsy. She suddenly noticed that she was unable to use her right arm and leg 2 hours ago. There is history of a prior stroke 2 months ago. She also complains of headache and dizziness. No history of trauma. She is on hydrochlorothiazide, lisinopril, pravastatin, and warfarin. For the past two months, her diet has been restricted to vegetables and an herbal tea which helps with her depression. Her vitals reveals a temperature of 38.5 degree Celsius, blood pressure of 200/112 mmHg, heart rate of 105 beats per minute, respiratory rate of 12 breaths per minute, and she is saturating at 92%, while breathing room air. Examination reveals an elderly woman, conscious and alert, not in any obvious painful distress. Lungs and cardiac were auscultations are unremarkable. Abdomen was non-tender, non-distended and without any hepatosplenomegaly. Neurological examination confirms the presenting complaints above. An immediate non-contrast CT of the brain done ruled out hemorrhage in the brain. You are strongly considering the use of intravenous recombinant TPA (alteplase) in this patient.

What is the next step in the management of this patient?]]

Answer A AnswerA::Administer IV recombinant TPA (alteplase) and transfer the patient to ICU for BP monitoring.
Answer A Explanation AnswerAExp::Thrombolysis is contraindicated in this patient.
Answer B AnswerB::Administer IV labetalol to control the blood pressure.
Answer B Explanation [[AnswerBExp::Elevated blood pressure is generally not treated until it is >220/120 mmHg, or when BP is <220/120 mmHg with evidence of end organ damage (e.g., myocardial infarction, aortic dissection, pulmonary edema, and hypertensive encephalopathy).]]
Answer C AnswerC::Transfer the patient to ICU for close monitoring of blood pressure and manage conservatively.
Answer C Explanation AnswerCExp::Conservative management is indicated in this patient.
Answer D AnswerD::Administer ASA 325 mg and manage conservatively.
Answer D Explanation AnswerDExp::A follow-up CT/MRI and speech and swallow evaluation are indicated before oral treatment can be initiated. Furthermore, all forms of anticoagulation are contraindicated in the first 24 hours of symptom onset.
Answer E AnswerE::Treat fever with oral acetaminophen
Answer E Explanation AnswerEExp::Fever may be managed with IV acetaminophen, but oral medications cannot be administered.
Right Answer RightAnswer::C
Explanation [[Explanation::This is a case of acute ischemic stroke. There was a history of stroke 2 months prior to presentation. The present stroke, despite anticoagulation with warfarin, may be explained by the intake of st. John’s wort (the herbal tea) which is known to increase the metabolism of warfarin, thereby reducing its anticoagulant actions.

The presence of a prior stroke less than 3 months ago, current intake of warfarin, and an elevated BP>180/110 mmHg makes the patient an unsuitable candidate for thrombolysis. Conservative management is usually indicated in the management of patients with an acute ischemic stroke ineligible for thrombolysis within the first 24 hours. In patients with contraindication to thrombolysis, elevated blood pressure is generally not treated until it is >220/120 mmHg, or when BP is <220/120 mmHg with evidence of end organ damage (e.g., myocardial infarction, aortic dissection, pulmonary edema, and hypertensive encephalopathy). The exclusion criteria for IV rTPA administration must be reviewed carefully before thrombolysis. They are:

Exclusion Criteria for IV Recombinant TPA Treatment

  • Less than 3 hours of onset

Significant head trauma or prior stroke in previous 3 months

Symptoms suggest subarachnoid hemorrhage

Arterial puncture at noncompressible site in previous 7 days

History of previous intracranial hemorrhage

Intracranial neoplasm, arteriovenous malformation, or aneurysm

Recent intracranial or intraspinal surgery

Elevated blood pressure (systolic >185 mm Hg or diastolic >110 mm Hg)

Active internal bleeding

Acute bleeding diathesis, including but not limited to

Platelet count <100,000/mm³

Heparin received within 48 hours, resulting in abnormally elevated aPTT greater than the upper limit of normal

Current use of anticoagulant with INR >1.7 or PT >15 seconds

Current use of direct thrombin inhibitors or direct factor Xa inhibitors with elevated sensitive laboratory tests (such as aPTT, INR, platelet count, and ECT; TT; or appropriate factor Xa activity assays)

Blood glucose concentration <50 mg/dL (2.7 mmol/L)

CT demonstrates multilobar infarction (hypodensity >1/3 cerebral hemisphere)

  • Relative exclusion criteria

Only minor or rapidly improving stroke symptoms (clearing spontaneously)

Pregnancy

Seizure at onset with postictal residual neurological impairments

Major surgery or serious trauma within previous 14 days

Recent gastrointestinal or urinary tract hemorrhage (within previous 21 days)

Recent acute myocardial infarction (within previous 3 months)

  • Between 3 and 4.5 hours of onset

Aged >80 years

Severe stroke (NIHSS>25)

Taking an oral anticoagulant regardless of INR

History of both diabetes and prior ischemic stroke

Educational Objective: Patients with acute ischemic stroke, who also have contraindications to thrombolysis treatment, are best managed conservatively within the first 24 hours of symptom onset. Elevated blood pressure is generally not treated until it is >220/120 mmHg, or when BP is <220/120 mmHg with evidence of end organ damage (e.g., myocardial infarction, aortic dissection, pulmonary edema, and hypertensive encephalopathy).

Reference: http://www.wikidoc.org/index.php/Stroke_resident_survival_guide
Educational Objective:
References: ]]

Approved Approved::No
Keyword WBRKeyword::Acute ischemic stroke, WBRKeyword::thrombolysis in stroke
Linked Question Linked::
Order in Linked Questions LinkedOrder::